Bright Infusions Marketing Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
- Paid Up Capital ₹ 2.50 M
- Company Age 10 Year, 2 Days
- Last Filing with ROC 31 Mar 2023
- Revenue Growth 21.37%
- Profit Growth 53.52%
- Ebitda 176.83%
- Net Worth -4.82%
- Total Assets -4.95%
About Bright Infusions Marketing
Bright Infusions Marketing Private Limited (BIMPL) is a Private Limited Indian Non-Government Company incorporated in India on 30 January 2015 and has a history of Ten years. Its registered office is in Kolkata, West Bengal, India.
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 2.50 M, as per Ministry of Corporate Affairs (MCA) records.
Alok Chamaria and Sangeeta Chamaria serve as directors at the Company.
Company Details
-
Location
Kolkata, West Bengal, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U74900WB2015PTC205140
-
Company No.
205140
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
30 Jan 2015
-
Date of AGM
29 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Kolkata
Industry
Who are the key members and board of directors at Bright Infusions Marketing?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Alok Chamaria
|
Director | 30-Jan-2015 | Current |
|
Sangeeta Chamaria
|
Director | 20-Aug-2019 | Current |
Financial Performance of Bright Infusions Marketing.
Bright Infusions Marketing Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 21.37% increase. The company also saw a substantial improvement in profitability, with a 53.52% increase in profit. The company's net worth dipped by a decrease of 4.82%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Bright Infusions Marketing?
Unlock access to Bright Infusions Marketing's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Mas Manors Development LimitedAlok Chamaria is a mutual person
-
Chakreshwari Exports Pvt.Ltd.
Alok Chamaria is a mutual person
-
S K Homes Private Limited
Sangeeta Chamaria is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Bright Infusions Marketing?
Unlock and access historical data on people associated with Bright Infusions Marketing, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Bright Infusions Marketing, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bright Infusions Marketing's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
